HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc. is a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform.

$5.05
As of 10/18/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/18/2019
Outstanding shares:  26,072,989
Average volume:  199,731
Market cap:   $139,751,221
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    43906K100
ISIN:        US43906K1007
Sedol:      
Valuation   (See tab for details)
PE ratio:   -2.18
PB ratio:   1.20
PS ratio:   7.03
Return on equity:   -48.00%
Net income %:   -304.06%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy